Christopher Francis Palmer

Person

Abingdon, Oxfordshire, GB

People

Patents Grantslast 30 patents

Information Patent Grant
Substituted benzo[b][1,4]oxazines and pyrido[3,2-b][1,4]oxazines as...
- Patent number 10,287,299
- Issue date May 14, 2019
- UCB Biopharma SPRL
- Gareth Neil Brace
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds which modulate the CB2 receptor
- Patent number 8,829,034
- Issue date Sep 9, 2014
- Boehringer Ingerlheim International GmbH
- Angela Berry
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Treatment of CRTH2-mediated diseases and conditions
- Patent number 8,314,257
- Issue date Nov 20, 2012
- Oxagen Limited
- David Middlemiss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds which modulate the CB2 receptor
- Patent number 8,299,111
- Issue date Oct 30, 2012
- Boehringer Ingelheim International GmbH
- Angela Berry
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Treatment of CRTH2-mediated diseases and conditions
- Patent number 8,198,314
- Issue date Jun 12, 2012
- Oxagen Limited
- David Middlemiss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of CRTH2-mediated diseases and conditions
- Patent number 8,163,936
- Issue date Apr 24, 2012
- Oxagen Limited
- David Middlemiss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of CRTH2-mediated diseases and conditions
- Patent number 8,163,931
- Issue date Apr 24, 2012
- Oxagen Limited
- David Middlemiss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds which modulate the CB2 receptor
- Patent number 7,935,715
- Issue date May 3, 2011
- Boehringer Ingelheim International GmbH
- Angela Berry
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds which modulate the CB2 receptor
- Patent number 7,928,123
- Issue date Apr 19, 2011
- Boehringer Ingelheim International GmbH
- Angela Berry
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of CRTH2-mediated diseases and conditions
- Patent number 7,582,672
- Issue date Sep 1, 2009
- Oxagen Limited
- David Middlemiss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
MODULATORS OF THE INTEGRATED STRESS RESPONSE PATHWAY
- Publication number 20230391763
- Publication date Dec 7, 2023
- EVOTEC INTERNATIONAL GMBH
- Holly Victoria ATTON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MODULATORS OF THE INTEGRATED STRESS RESPONSE PATHWAY
- Publication number 20220227747
- Publication date Jul 21, 2022
- EVOTEC INTERNATIONAL GMBH
- Holly ATTON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Benzoxazinone Derivatives and Analogues Thereof as Modulators of TN...
- Publication number 20180134728
- Publication date May 17, 2018
- UCB Biopharma SPRL
- Gareth Neil Brace
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Sulfone Compounds Which Modulate The CB2 Receptor
- Publication number 20120015988
- Publication date Jan 19, 2012
- Boehringer Ingelheim International GmbH
- Eugene Richard Hickey
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds Which Modulate The CB2 Receptor
- Publication number 20110130431
- Publication date Jun 2, 2011
- Boehringer Ingelheim International GmbH
- Angela BERRY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds Which Modulate the CB2 Receptor
- Publication number 20110071127
- Publication date Mar 24, 2011
- Boehringer Ingelheim International GmbH
- Angela BERRY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MICROCRYSTALLINE (5-FLUORO-2-METHYL-3-QUINOLIN-2-YLMETHYL-INDOL-1-Y...
- Publication number 20100041699
- Publication date Feb 18, 2010
- OXAGEN LIMITED
- Edward Andrew Boyd
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Treatment of CRTH2-mediated diseases and conditions
- Publication number 20090023788
- Publication date Jan 22, 2009
- Oxagen Limited
- David Middlemiss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment of CRTH2-mediated diseases and conditions
- Publication number 20090018138
- Publication date Jan 15, 2009
- Oxagen Limited
- David Middlemiss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment of CRTH2-mediated diseases and conditions
- Publication number 20090018139
- Publication date Jan 15, 2009
- Oxagen Limited
- David Middlemiss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment of CRTH2-Mediated diseases and conditions
- Publication number 20090018338
- Publication date Jan 15, 2009
- Oxagen Limited
- David Middlemiss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds which Modulate the CB2 Receptor
- Publication number 20080081822
- Publication date Apr 3, 2008
- Angela Berry
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds Which Modulate The CB2 Receptor
- Publication number 20080039464
- Publication date Feb 14, 2008
- Angela BERRY
- C07 - ORGANIC CHEMISTRY

Christopher Francis Palmer

Person

Patents Grantslast 30 patents

Substituted benzo[b][1,4]oxazines and pyrido[3,2-b][1,4]oxazines as...

Compounds which modulate the CB2 receptor

Treatment of CRTH2-mediated diseases and conditions

Compounds which modulate the CB2 receptor

Treatment of CRTH2-mediated diseases and conditions

Treatment of CRTH2-mediated diseases and conditions

Treatment of CRTH2-mediated diseases and conditions

Compounds which modulate the CB2 receptor

Compounds which modulate the CB2 receptor

Compounds for the treatment of CRTH2-mediated diseases and conditions

Patents Applicationslast 30 patents

MODULATORS OF THE INTEGRATED STRESS RESPONSE PATHWAY

MODULATORS OF THE INTEGRATED STRESS RESPONSE PATHWAY

Benzoxazinone Derivatives and Analogues Thereof as Modulators of TN...

Sulfone Compounds Which Modulate The CB2 Receptor

Compounds Which Modulate The CB2 Receptor

Compounds Which Modulate the CB2 Receptor

MICROCRYSTALLINE (5-FLUORO-2-METHYL-3-QUINOLIN-2-YLMETHYL-INDOL-1-Y...

Treatment of CRTH2-mediated diseases and conditions

Treatment of CRTH2-mediated diseases and conditions

Treatment of CRTH2-mediated diseases and conditions

Treatment of CRTH2-Mediated diseases and conditions

Compounds which Modulate the CB2 Receptor

Compounds Which Modulate The CB2 Receptor